This is an important insight because IgG1 is established to be safe for antibody therapy in other fields than infectious diseases such as oncology and auto-immune diseases (48), is easier to produce and purify than IgG3 (46) and has a longer half-life than IgG3 (49). This evidence concerns the gene IGHG3 and infectious disease.